Citigroup »

Immix Biopharma shares owned by Citigroup

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $22k 2.5k 9.11

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Immix Biopharma

Henderson Group
Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Vanguard Capital Management
Millennium Management
Adage Capital Partners GP
Logos Global Management
Vanguard Group
Bleichroeder
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
BlackRock
Geode Capital Management

View all funds holding Immix Biopharma